Gene-Modified Stem Cell Therapy for Subjects With Transfusion-dependent Beta-thalassemia

NCT07680803 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

9

Enrollment

OTHER

Sponsor class

Conditions

Transfusion-dependent Beta-Thalassemia

Interventions

GENETIC: FT007

Sponsor

Fondazione Telethon

Collaborators

[object Object]